{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1164.31","meta":{"versionId":"5","lastUpdated":"2017-06-21T01:00:04.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"LUGPA Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-06-21"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.31","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1164.31"}],"version":"20170621","name":"ActiveSurveillanceForVeryLowAndLowRiskProstateCancer","title":"Active surveillance for very low and low risk prostate cancer","status":"active","experimental":false,"date":"2017-06-21T01:00:04-04:00","publisher":"LUGPA Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values focuses on the designation of active surveillance for very low and low risk prostate cancer.),(Data Element Scope: The intent of this data element is to identify active surveillance as the initial therapy option for very low and low risk prostate cancer.),(Inclusion Criteria: Active surveillance),(Exclusion Criteria: none)","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"424313000","display":"Active surveillance (regime/therapy)"}]}]},"expansion":{"identifier":"urn:uuid:cf3ea60d-0bfa-4a1c-992e-74c3bc450b11","timestamp":"2023-12-10T22:31:09-05:00","total":1,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"424313000","display":"Active surveillance (regime/therapy)"}]}}